Clinical Trial Update: Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD [Phase 2]

View source ↗

Summary

Phase 2 dose-escalation trial evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of voxelotor in patients with sickle cell disease was t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Voxelotor (voxelotor)

Snippet

Sponsor: Pfizer | Conditions: Sickle Cell Disease | Phase 2 | Status: TERMINATED | Results posted: 2023-11-21